Showing results (2871-2880 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 12, 2007
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotideNicole Wiedenmann, Masashi Koto, Uma Raju, et al.
Investigational New Drugs|May 12, 2007
Silencing of endo-exonuclease expression sensitizes mouse B16F10 melanoma cells to DNA damaging agentsSibgat A Choudhury, Paul Kauler, Slobodan Devic, et al.
Investigational New Drugs|January 24, 2007
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomasQuincy S C Chu, Bahram Forouzesh, Samira Syed, et al.
Investigational New Drugs|September 8, 2006
Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinomaMinaxi Jhawer, Lee Rosen, Janet Dancey, et al.
Investigational New Drugs|September 14, 2006
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedulesHarold J Burstein, Beth Overmoyer, Rebecca Gelman, et al.
Investigational New Drugs|August 1, 1990
Phase II study of tallysomycin S10b in patients with advanced head and neck cancerC Nicaise, W K Hong, W Dimery, et al.
Investigational New Drugs|October 21, 2006
Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumorsLuis H Camacho, Jon Olson, William P Tong, et al.
Investigational New Drugs|October 21, 2006
A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancerS J Dawson, M Michael, J Biagi, et al.
Investigational New Drugs|May 16, 2006
Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity studyHector Soto Parra, Raffaele Cavina, Fiorenza Latteri, et al.
Investigational New Drugs|May 13, 2021
Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancerXue Zhou, Xiaowei Zhu, Junchao Yao, et al.
Pageof 372